Recent data suggests that ΔNTP63α represents a proto-oncogene, whereas TP63 behaves as a haplo-insufficient tumour suppressor and that these latter functions can be de-regulated by certain TP53 mutations (17–19). Here, TP63 is linked to neoplasm.